What drugs should be combined with Axitinib?

Axitinib (Axitinib) is usually used alone as a stand-alone targeted drug to treat renal cell carcinoma (RCC, kidney cancer). However, in some cases, doctors may consider combining axitinib with other drugs to enhance the effectiveness of the treatment or address specific treatment challenges, depending on the patient's specific condition and condition.

1.Immunotherapy drugs: In some cases, axitinib may be used in combination with immunotherapy drugs to enhance the immune system's attack on cancer cells. Combined application can act on tumors simultaneously through different mechanisms, improving the comprehensiveness of treatment.

2.Other targeted therapy drugs: In the treatment of renal cell carcinoma, axitinib may be used in combination with other targeted therapy drugs (such as sorafenib, paxilitamide, etc.) to form a combined treatment plan. This combination may achieve a more comprehensive therapeutic effect by interfering with multiple signaling pathways simultaneously.

3.Chemotherapy drugs: Although targeted therapy drugs have made significant progress in the treatment of renal cell carcinoma, in some cases, axitinib may be used in combination with traditional chemotherapy drugs, especially in patients who have received other treatments but still have tumor progression.

Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.